Cyclosporine treatment of psoriatic erythroderma complicated by bacterial sepsis

J Eur Acad Dermatol Venereol. 1999 Mar;12(2):197-8. doi: 10.1111/j.1468-3083.1999.tb01027.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acitretin / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Cefazolin / therapeutic use
  • Cephalosporins / therapeutic use
  • Cyclosporine / therapeutic use*
  • Dermatitis, Exfoliative / complications
  • Dermatitis, Exfoliative / drug therapy*
  • Dermatologic Agents / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Keratolytic Agents / therapeutic use
  • Male
  • Middle Aged
  • Psoriasis / complications
  • Psoriasis / drug therapy*
  • Sepsis / microbiology
  • Staphylococcal Infections / complications*
  • Staphylococcal Infections / drug therapy
  • Streptococcal Infections / complications*
  • Streptococcal Infections / drug therapy
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Dermatologic Agents
  • Immunosuppressive Agents
  • Keratolytic Agents
  • Vancomycin
  • Cyclosporine
  • Cefazolin
  • Acitretin